Chairman Jiang Xiaomeng proposed: "Four Focuses, Four Precautions" in 2017"
Release time:
2020-07-31
2016 annual summary commendation conference held on 1# April 20 , Jiang Xiaomeng, secretary of the party Committee and chairman of the group company, made a concluding speech, fully affirming the company's work in 2016 and putting forward the requirements of "four focuses and four precautions" for the enterprise management work in 2017 . In his concluding speech entitled "Continuously Improve the Competitiveness of the Organization and Make persistent efforts to Do All the Work in
", Jiang Xiaomeng said that in 2016 , the Group Company won the Silver Award of Zhejiang Industrial Award, the trademark "Peak" was recognized as a well-known trademark in China, and Yunnan Peak and Tianjin Natural Products Company achieved the best results in history, daye Peak has the lowest production cost and the best benefit in the region. Peak Pharmaceutical has made a good start in cooperation and upgrading. At the same time, Yunnan Peak, Daye Peak, Pharmaceutical Company, Natural Products Company and other diligent and continuous development teams have emerged. A large number of individuals and collectives who work hard without complaining are worthy of praise and affirmation. The ancients said that "good players seek momentum", "potential" is the situation, trend, situation, and development trend related to the overall situation; only those who seek momentum can stand high and see far. Only by being good at seeking the situation and then being good at taking advantage of the situation can we seize the first opportunity, find a new situation and create a new realm. New policies and new demands are forcing us to continue to reform and innovate. Managers at all levels must grasp the trend of industry and national policies in a timely manner, actively respond, follow the trend, and move in order to achieve better performance. In combination with the arrangement of the work in
in the general manager's report, Jiang Xiaomeng requires cadres and employees at all levels of the company to make great efforts to achieve "four focuses and four precautions", I .e. focusing on the market, focusing on costs, focusing on efficiency, focusing on development, and preventing and controlling risks, policy risks, security risks and financial risks. Focus on the market. Only by selling products for profit can the enterprise continue to produce and develop. For the peak, the two main businesses are in fully competitive industries. How can cement increase both volume and price, how can the pharmaceutical industry increase the sales volume of key products, how can enterprises make market recognition and customer recognition, and how to further expand business models and channels are all issues that need to be carefully studied. All enterprises should continue to expand the market, pay close attention to customer control and training, so that sales performance to a higher level.
Focus cost. Peak cement in recent years, the good performance, the core competitiveness is the cost. The company's other industries are also facing cost pressure, we must start from the procurement, process, management and other aspects of strict control, do everything possible to reduce costs, so as to enhance the market competitiveness of products.
Focus efficiency. There is still a considerable gap between the company's management efficiency, production efficiency and work efficiency compared with the advanced enterprises in the same industry. In recent years, good business performance has also made some managers inert and have a weak sense of urgency. Therefore, it is necessary to further strengthen the organizational structure optimization and post optimization to ensure that efficiency is given priority.
Focus on development. Only to maintain a healthy and stable development, development speed and efficiency of coordinated matching, enterprises can ensure long-term. If Jianfeng wants to become a century-old enterprise, it must further do a good job in development, and continue to be stronger, better, and bigger.
Jiang Xiaomeng pointed out that while enterprises achieve "four focuses" in the future development process, they must do a good job of "four precautions". The subordinate enterprises of the peak have many points and long lines, and they should rely on the system and internal control to manage the whole process, so as to ensure that the company's interests are not lost and prevent and control risks. All new policies related to enterprises and industries should be carefully studied and judged, and investment and technological transformation should be carried out according to the requirements to prevent policy risks. Safety is the eternal topic of enterprises. No matter how good the performance is, it will be empty, therefore, we must adhere to the "zero tolerance" attitude to grasp safety in production, prevent safety risks; do a good job in the planning and use of funds, ensure sufficient and smooth cash flow, strictly block fund loopholes, and prevent financial risks.
Jiang Xiaomeng hopes that managers at all levels will keep in mind the mission of "creating a century-old peak", always keep a clear mind, a rigorous style of acting, a work style of being public with one heart and one mind, put the interests of the enterprise first, give full play to the initiative of all levels of the team, carry forward positive energy, work together with high morale, and hand over a more beautiful answer in
. (this newspaper reporter)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11